Objective
To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies.
Management group
Bellevue Asset Management
Launch date
02/12/2016
Domicile
United Kingdom
Fund manager
Paul Major, Brett Darke
Dividend frequency
Semi-Annually
Wind-up provisions
There are no specific provisions for the termination of the life of the Company.
Total assets (m) Market Cap (m) Price (last close) NAV Dividend dates Discount / premium (%) Gearing (%) Dividend yield (%) Ongoing charge (%)
991.67 880.76 151.00 149.45 Feb, Jul 1.04 11 4.28 1.08 (30/11/2021)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Dividend type Special dividend Financial year
17/03/2022 28/04/2022 3.015 Capital No 2021
29/07/2021 03/09/2021 3.015 Capital No 2021
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
Bellevue Healthcare Share price total return -12.9 20.1 56.2 N/A
Biotechnology & Healthcare AIC sector Share price total return -15.8 2.2 30.8 298.2
Scroll

Share structure

Number of shares
583,282,380

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 1,087,002 19,898,247 238,497,564 990,232,446
Average N/A 947,536 942,678 782,174
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 1.64 31.37 441.09 1,569.06
Average N/A 1.49 1.74 1.24
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BZCNLL95 BBH GBX London Stock Exchange - MAIN
Scroll

Top holdings

Data as at : 30/11/2021

Investment % of total assets
Jazz Pharmaceuticals PLC 7.6
Insmed Inc 7.1
Anthem Inc 5.9
Humana Inc 5.5
Option Care Health Inc 5.5
Sarepta Therapeutics Inc 5.0
Tandem Diabetes Care Inc 4.7
UnitedHealth Group Inc 4.5
Bristol-Myers Squibb Co 4.2
Amedisys Inc 3.9

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.